Dexchlorpheniramine


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 45.7%
Premedication 11.4%
Anaemia Haemolytic Autoimmune 6.3%
Angioedema 3.4%
Chemotherapy 3.4%
Graft Versus Host Disease 3.4%
Polyarthritis 3.4%
Breast Cancer 2.9%
Eczema 2.3%
Endometrial Cancer 2.3%
Infection Prophylaxis 2.3%
Product Used For Unknown Indication 2.3%
Renal Transplant 2.3%
Skin Test Positive 1.7%
Antifungal Prophylaxis 1.1%
Enterococcal Infection 1.1%
Mixed Connective Tissue Disease 1.1%
Prophylaxis Against Graft Versus Host Disease 1.1%
Pruritus 1.1%
Rash 1.1%
Urticaria 17.9%
Toxic Epidermal Necrolysis 10.7%
Neutropenia 7.1%
Respiratory Arrest 7.1%
Tachycardia 7.1%
Drug Ineffective 3.6%
Electrocardiogram St Segment Abnormal 3.6%
Headache 3.6%
Hypothyroidism 3.6%
Malaise 3.6%
Renal Failure 3.6%
Sepsis 3.6%
Serum Sickness 3.6%
Tinnitus 3.6%
Tuberculosis 3.6%
Ventricular Extrasystoles 3.6%
Vertigo 3.6%
Vision Blurred 3.6%
White Blood Cell Count Decreased 3.6%
Concomitant
Premedication 27.2%
Product Used For Unknown Indication 12.0%
Breast Cancer 10.3%
Drug Use For Unknown Indication 9.0%
Rheumatoid Arthritis 8.3%
Her-2 Positive Breast Cancer 4.5%
Prophylaxis 4.5%
Hiv Infection 3.0%
Diffuse Large B-cell Lymphoma 2.8%
Non-hodgkin's Lymphoma 2.3%
Non-small Cell Lung Cancer 2.1%
Anxiety 1.9%
Hypertension 1.9%
Exposure During Pregnancy 1.7%
Stem Cell Transplant 1.7%
Aspergillosis 1.5%
Diabetes Mellitus 1.5%
Constipation 1.3%
Hormone Replacement Therapy 1.3%
Neutropenia 1.3%
Death 19.0%
Ventricular Septal Defect 10.7%
Vomiting 7.1%
Pneumonia 6.0%
Neutropenic Sepsis 4.8%
Oxygen Saturation Decreased 4.8%
Pruritus Generalised 4.8%
Serum Sickness 4.8%
Urticaria 4.8%
Cryoglobulinaemia 3.6%
Myocardial Infarction 3.6%
Nephritic Syndrome 3.6%
Skin Infection 3.6%
Toxic Epidermal Necrolysis 3.6%
White Blood Cell Count Decreased 3.6%
Cardiac Arrest 2.4%
Clostridium Difficile Colitis 2.4%
Delirium 2.4%
Encephalopathy 2.4%
Gallbladder Disorder 2.4%

Drug Data